ClinicalTrials.gg
CompletedNCT07293104ChiPSUpdated Dec 24, 2025

Children in Pancreatic Surgery: Indications, Procedures and Outcomes

An observational study in Pancreatic Surgery and Children, sponsored by Medizinische Hochschule Brandenburg Theodor Fontane. Completed. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2025-12-24.

Sponsored by Medizinische Hochschule Brandenburg Theodor Fontane · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
761
Ages
Up to 18 Years
Sex
All
01

Study summary

Pediatric patients differ in a variety of properties from adult populations, but comprehensive multicenter or population-based data is missing for pancreatic surgery. This study aimed to evaluate indications, complications, and mortality in pediatric pancreatic surgery.

Read the detailed description

This retrospective observational population-based cohort study analzes the German Diagnostic-Related Group database and included all children with pancreatic procedures between 2010 and 2023. The primary outcomes are mortality rates, complication rates, and sex differences related to surgical indication and pancreatic procedure. Descriptive epidemiological and multivariable regression analyses are performed to identify risk factors of mortality and occurrence of perioperative complications.

02

Conditions studied

  • Pancreatic Surgery
  • Children

Keywords

  • Chidren
  • Pancreatic surgery
  • Surgical outcomes
03

In context

Lead sponsor

Medizinische Hochschule Brandenburg Theodor Fontane is the lead sponsor of 17 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All persons addmitted to a German hospital between 2010 and 2023. Population-based dataset.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • stationary hospital admission
  • pancreatic surgical procedure

Exclusion criteria

Exclusion Criteria:

  • unknown sex or age
  • admission for pancreas tranplantation
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
761 participants (actual)
Patient registry
No

Groups and cohorts

  • Pancreatic tumor

    Procedure: Pancreatoduodenectomy · Procedure: Total pancreatectomy · Procedure: Distal pancreatectomy · Procedure: Anastomosis of the pancreatic duct · Procedure: Incision of the pancreas · Procedure: Internal drainage of the pancreas · Procedure: Local excision destruction pancreas · Procedure: Marsupialization of a pancreatic cyst · Procedure: Segmental pancreatic resection

  • Chronic pancreatitis

    Procedure: Pancreatoduodenectomy · Procedure: Total pancreatectomy · Procedure: Distal pancreatectomy · Procedure: Anastomosis of the pancreatic duct · Procedure: Incision of the pancreas · Procedure: Internal drainage of the pancreas · Procedure: Local excision destruction pancreas · Procedure: Marsupialization of a pancreatic cyst · Procedure: Segmental pancreatic resection

  • Trauma

    Procedure: Pancreatoduodenectomy · Procedure: Total pancreatectomy · Procedure: Distal pancreatectomy · Procedure: Anastomosis of the pancreatic duct · Procedure: Incision of the pancreas · Procedure: Internal drainage of the pancreas · Procedure: Local excision destruction pancreas · Procedure: Marsupialization of a pancreatic cyst · Procedure: Segmental pancreatic resection

  • Extra-pancreatic neoplasm

    Procedure: Pancreatoduodenectomy · Procedure: Total pancreatectomy · Procedure: Distal pancreatectomy · Procedure: Anastomosis of the pancreatic duct · Procedure: Incision of the pancreas · Procedure: Internal drainage of the pancreas · Procedure: Local excision destruction pancreas · Procedure: Marsupialization of a pancreatic cyst · Procedure: Segmental pancreatic resection

  • Other diseases

    Procedure: Pancreatoduodenectomy · Procedure: Total pancreatectomy · Procedure: Distal pancreatectomy · Procedure: Anastomosis of the pancreatic duct · Procedure: Incision of the pancreas · Procedure: Internal drainage of the pancreas · Procedure: Local excision destruction pancreas · Procedure: Marsupialization of a pancreatic cyst · Procedure: Segmental pancreatic resection

Interventions

  • ProcedurePancreatoduodenectomy

    Procedure codes: 5-524.1; 5-524.2; 5-524.3

  • ProcedureTotal pancreatectomy

    Procedure codes: 5-525.\*

  • ProcedureDistal pancreatectomy

    Procedure code: 5-524.0

  • ProcedureAnastomosis of the pancreatic duct

    Procedure codes: 5-527.\*

  • ProcedureIncision of the pancreas

    Procedure codes: 5-520.\*

  • ProcedureInternal drainage of the pancreas

    Procedure codes: 5-523.\*

  • ProcedureLocal excision destruction pancreas

    Procedure codes: 5-521.\*

  • ProcedureMarsupialization of a pancreatic cyst

    Procedure codes: 5-522.\*

  • ProcedureSegmental pancreatic resection

    Procedure codes: 5-524.0\*; 5-524-x; 5-524.y

06

What researchers measure

Primary outcomes

  1. Mortality rate

    Perioperative death

    Time frame: 30 days

Secondary outcomes

  1. Complication rates

    Perioperative surgical-related complication

    Time frame: 30 days

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — The data is held and provided by the Federal Statistical Office of Germany and the statistical offices of the federal states. Due to data privacy regulations, data sharing is strictly prohibited by German law. Furthermore, the data was evaluated exclusively within the framework of controlled remote data analysis. This meant that we never had direct access to the raw data.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2010 to primary completion in Dec 2023, 167 months.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 5, 2025
First posted
Dec 18, 2025
StartActual
Jan 1, 2010
Primary completionActual
Dec 31, 2023
CompletionActual
Dec 31, 2023
Last update
Dec 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07293104
Lead sponsor
Medizinische Hochschule Brandenburg Theodor Fontane
Responsible party
Richard Hunger (Principal investigator, Medizinische Hochschule Brandenburg Theodor Fontane) — Principal investigator
First posted
Dec 18, 2025
Start date
Jan 1, 2010
Primary completion
Dec 31, 2023
Completion
Dec 31, 2023
Last update
Dec 24, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion